Market Closed - Australian S.E. 01:10:19 2024-03-27 am EDT 5-day change 1st Jan Change
0.3 AUD +361.54% Intraday chart for Osteopore Limited +341.18% -54.55%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Osteopore Secures Singapore, Vietnam Market Approvals for Orthopedic Products MT
Osteopore Completes Clinical Trial of Customized Scaffolds for Bone Reconstruction MT
Osteopore Consolidates Capital MT
Osteopore Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Slowing Domestic Inflation Buoy Australian Shares to Eight-Day Winning Streak MT
Osteopore Posts 61% Jump in Q4 Revenue; Shares Rise 6% MT
Osteopore Surpasses Sales of 100,000 Implants Globally MT
Osteopore Enters Bridging Loan Agreement with Advance Opportunities Fund I MT
Osteopore Limited announced that it expects to receive SGD 1 million in funding CI
Osteopore Secures Clearance to Supply Neurosurgery Products to Hainan, China MT
Osteopore in Talks to Distribute Products in China MT
Osteopore Limited Announces Resignation of Deborah Ho as Joint Company Secretary CI
Osteopore Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Osteopore Signs Deal to Commercialize Products in China; Shares Rise 4% MT
Osteopore Promotes Operating, Technology Chief to CEO MT
Osteopore Limited Announces Executive Changes CI
Osteopore Limited Appoints Hon. Michael Keenan as A Non-Executive Director CI
Osteopore Joins Forces to Commercialize Implant Products in China; Shares Rally 11% MT
Osteopore's Mesh Product Gets Reimbursement Approval from South African Insurer; Shares Gain 7% MT
Osteopore Limited Announces Change of Registered Office Address CI
Osteopore Raises AU$1.7 Million Via Entitlement Offer MT
Osteopore to Commercialize Bone and Tissue Regeneration Technology MT
Osteopore's US Partner Signs Sub-Distribution Deal for Cranial Implant Products; Shares Rally 15% MT
Osteopore Completes Acquisition of Medical Distribution Businesses MT
Osteopore Limited Auditor Raises 'Going Concern' Doubt CI
Chart Osteopore Limited
More charts
Osteopore Limited is an Australia-based medical technology company. The Company is engaged in commercializing a range of bespoke products specifically engineered to facilitate bone healing across multiple therapeutic areas. The Company's patented technology fabricates specific micro-structured scaffolds for bone regeneration through three-dimensional (3D) printing and bioresorbable material. The Company's Osteoplug in plug and strip configuration fills craniotomy gaps effortlessly. It also promotes bone tissue integration, from the skull to the bone flap. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. It also offers craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, minimally invasive skull base surgery, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, immediate implant loading, and more.
More about the company
  1. Stock
  2. Equities
  3. Stock Osteopore Limited - Australian S.E.
  4. News Osteopore Limited
  5. Osteopore, Singaporean Healthcare Group Enter Deal to Develop New Regenerative Bone, Tissue Products